Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PercutAneous INTervention With Biodegradable- Polymer Based Paclitaxel-eluting, Sirolimus-eluting, or Bare Stents for the Treatment of de Novo Coronary Lesions.

NCT00752362 is registered in ClinicalTrials.gov with Sahajanand Medical Technologies Limited as lead sponsor.

NCT NCT00752362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00752362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PercutAneous INTervention With Biodegradable- Polymer Based Paclitaxel-eluting, Sirolimus-eluting, or Bare Stents for the Treatment of de Novo Coronary Lesions.
Lead sponsor
Sahajanand Medical Technologies Limited
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
Not reported
Enrollment
280 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

coronary restenosis